Frontiers in Immunology · 2021 · 30 citations · 35 references
Life SciencesImmunologyPathologyInflammationInnate ImmunityMucosal ImmunologyGastrointestinal ImmunologyGastrointestinal InflammationInflammatory Bowel DiseaseInflammatory SignalingMucosal InflammationNeutrophil BiologyColonic InflammationEnteric InflammationInflammatory Bowel Disease DysbiosisInflammatory Bowel Disease PathogenesisInflammatory Bowel Disease PathophysiologyIntestinal Barrier PermeabilityIntestinal HomeostasisTrem1 Signaling
Triggering receptor expressed on myeloid cell-1 (TREM-1) signaling is expressed on neutrophils and monocytes that is necessary for the successful antimicrobial response and resolution of inflammation in the gut. In this study, we determined the effect of an anti-TREM-1 agonistic antibody (α-TREM-1) on colitis and identify its underlying mechanism of action. Administration of α-TREM-1 alleviated colitis in mice and resolved dysbiosis, which required TLR4/Myd88 signaling. α-TREM-1 increased the production of neutrophil extracellular traps and interleukin-22 by CD177 + neutrophils, which led to pathogen clearance and protection of the intestinal barrier. TREM-1 activation using an α-TREM-1 antibody protects against colitis by rebalancing the microbiota and protecting the epithelium against the immune response as well as modulates the function of neutrophils and macrophages. These results highlight the importance of the TREM-1 pathway in intestinal homeostasis and suggest that α-TREM-1 treatment may be an effective therapeutic strategy for inflammatory bowel disease.
35
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Eran Elinav, Till Strowig, Andrew L. Kau et al. · Cell · 2011 · 2K citations · Full text
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
Axel Bouchon, Fabio Facchetti, Markus A. Weigand et al. · Nature · 2001 · 1.1K citations